Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 154
Filter
1.
Transplant Proc ; 56(3): 712-714, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38355371

ABSTRACT

BACKGROUND: Inappropriate matching of motor and sensory fibers after nerve repair or grafting can lead to nerve recovery failure. Identifying the motor and sensory fascicles enables surgeons to match them accurately and correctly align nerve stumps, which is crucial for neural regeneration. Very few methods have been reported to differentiate between the sensory and motor nerve fascicles, and the replicability of these techniques remains unestablished. In this study, we aimed to assess the accuracy of axonal cholinesterase (CE) histochemical staining in distinguishing motor and sensory nerve fibers. METHODS: The femoral and sciatic nerves were harvested from rats. The specimens were immediately cut, frozen in isopentane, and cooled with liquid nitrogen. Nerve serial cross-sections were processed for hematoxylin and eosin staining, followed by CE histochemistry. The staining protocol solutions included acetylthiocholine iodide, phosphate buffer, cobalt sulfate hydrate, potassium phosphate monobasic, sulfuric acid, sodium bicarbonate, glutaraldehyde, and ammonium sulfide. RESULTS: Cross-sections of nerves containing efferent and afferent nerve fibers in segregated fascicles showed that CE activity was confined to motor neurons. A histochemical study revealed that motor fibers with high cholinesterase activity can be differentiated from sensory fibers. The motor branches of the femoral and sciatic nerves showed specific axonal staining, whereas the sensory branch did not show any specific staining. CONCLUSION: CE histochemical staining is a useful technique for distinguishing between motor and sensory nerve fibers. It can be potentially useful in improving the outcomes of nerve grafts or extremity allotransplantation surgery.


Subject(s)
Cholinesterases , Motor Neurons , Sciatic Nerve , Staining and Labeling , Animals , Sciatic Nerve/enzymology , Rats , Cholinesterases/metabolism , Cholinesterases/analysis , Staining and Labeling/methods , Motor Neurons/enzymology , Axons/enzymology , Sensory Receptor Cells/enzymology , Male , Femoral Nerve , Rats, Sprague-Dawley
2.
Cell ; 187(1): 44-61.e17, 2024 01 04.
Article in English | MEDLINE | ID: mdl-38134932

ABSTRACT

Cytokines employ downstream Janus kinases (JAKs) to promote chronic inflammatory diseases. JAK1-dependent type 2 cytokines drive allergic inflammation, and patients with JAK1 gain-of-function (GoF) variants develop atopic dermatitis (AD) and asthma. To explore tissue-specific functions, we inserted a human JAK1 GoF variant (JAK1GoF) into mice and observed the development of spontaneous AD-like skin disease but unexpected resistance to lung inflammation when JAK1GoF expression was restricted to the stroma. We identified a previously unrecognized role for JAK1 in vagal sensory neurons in suppressing airway inflammation. Additionally, expression of Calcb/CGRPß was dependent on JAK1 in the vagus nerve, and CGRPß suppressed group 2 innate lymphoid cell function and allergic airway inflammation. Our findings reveal evolutionarily conserved but distinct functions of JAK1 in sensory neurons across tissues. This biology raises the possibility that therapeutic JAK inhibitors may be further optimized for tissue-specific efficacy to enhance precision medicine in the future.


Subject(s)
Dermatitis, Atopic , Immunity, Innate , Lung , Sensory Receptor Cells , Animals , Humans , Mice , Cytokines , Dermatitis, Atopic/immunology , Inflammation , Lung/immunology , Lymphocytes , Sensory Receptor Cells/enzymology
3.
PLoS Pathog ; 18(1): e1010281, 2022 01.
Article in English | MEDLINE | ID: mdl-35100323

ABSTRACT

We previously reported that HSV-1 infectivity in vitro and in vivo requires HSV glycoprotein K (gK) binding to the ER signal peptide peptidase (SPP). Anterograde-retrograde transport via peripheral nerves between the site of infection (i.e., eye) and the site of latency (neurons) is a critical process to establish latency and subsequent viral reactivation. Given the essential role of neurons in HSV-1 latency-reactivation, we generated mice lacking SPP specifically in peripheral sensory neurons by crossing Advillin-Cre mice with SPPfl/fl mice. Expression of SPP mRNA and protein were significantly lower in neurons of Avil-SPP-/- mice than in control mice despite similar levels of HSV-1 replication in the eyes of Avil-SPP-/- mice and control mice. Viral transcript levels in isolated neurons of infected mice on days 2 and 5 post infection were lower than in control mice. Significantly less LAT, gB, and PD-1 expression was seen during latency in isolated neurons and total trigeminal ganglia (TG) of Avil-SPP-/- mice than in control mice. Finally, reduced latency and reduced T cell exhaustion in infected Avil-SPP-/- mice correlated with slower and no reactivation. Overall, our results suggest that blocking SPP expression in peripheral sensory neurons does not affect primary virus replication or eye disease but does reduce latency-reactivation. Thus, blocking of gK binding to SPP may be a useful tool to reduce latency-reactivation.


Subject(s)
Aspartic Acid Endopeptidases/metabolism , Keratitis, Herpetic/virology , Sensory Receptor Cells/virology , Virus Activation/physiology , Virus Latency/physiology , Animals , Herpesvirus 1, Human , Mice , Sensory Receptor Cells/enzymology , Virus Replication/physiology
4.
Dev Cell ; 56(7): 976-984.e3, 2021 04 05.
Article in English | MEDLINE | ID: mdl-33823136

ABSTRACT

Axon remodeling through sprouting and pruning contributes to the refinement of developing neural circuits. A prominent example is the pruning of developing sensory axons deprived of neurotrophic support, which is mediated by a caspase-dependent (apoptotic) degeneration process. Distal sensory axons possess a latent apoptotic pathway, but a cell body-derived signal that travels anterogradely down the axon is required for pathway activation. The signaling mechanisms that underlie this anterograde process are poorly understood. Here, we show that the tumor suppressor P53 is required for anterograde signaling. Interestingly loss of P53 blocks axonal but not somatic (i.e., cell body) caspase activation. Unexpectedly, P53 does not appear to have an acute transcriptional role in this process and instead appears to act in the cytoplasm to directly activate the mitochondrial apoptotic pathway in axons. Our data support the operation of a cytoplasmic role for P53 in the anterograde death of developing sensory axons.


Subject(s)
Axons/physiology , Sensory Receptor Cells/physiology , Tumor Suppressor Protein p53/physiology , Animals , Axons/enzymology , Axons/metabolism , Caspases/metabolism , Cells, Cultured , Cytoplasm/metabolism , Mice , Protein Domains , Sensory Receptor Cells/enzymology , Sensory Receptor Cells/metabolism , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/genetics , bcl-X Protein/antagonists & inhibitors
5.
Eur Rev Med Pharmacol Sci ; 24(13): 7399-7411, 2020 07.
Article in English | MEDLINE | ID: mdl-32706079

ABSTRACT

OBJECTIVE: The efficacy of melatonin as an analgesic agent has been well documented in animals and humans. However, the underlying mechanisms by which melatonin exerts antinociceptive effects on inflammatory pain are poorly understood. Here, we investigated the potential of melatonin to ameliorate inflammatory pain. MATERIALS AND METHODS: In vitro, ND7/23 neurons were treated with capsaicin. We used PCR and Western blot analyses to detect the expression of neuronal nitric oxide synthase (nNOS) in response to melatonin. Orofacial inflammatory pain was induced by 4% formalin administration on the right whisker pad of Sprague Dawley (SD) rats. The analgesic effect of melatonin was evaluated using mechanical threshold analyses. The expression level of nNOS in the trigeminal ganglion (TG) and trigeminal nucleus caudalis (Vc) neurons was assessed by RNAscope and immunohistochemistry. RESULTS: In vitro, capsaicin upregulated the expression of nNOS, which was dose-dependently reversed by melatonin pretreatment (p < 0.001). In a rat model of orofacial inflammatory pain, melatonin pretreatment significantly attenuated mechanical allodynia in both the acute and chronic phases (p < 0.05). Furthermore, melatonin decreased the formalin-evoked elevated nNOS mRNA and protein levels in the TG and Vc neurons in the acute and chronic phases (p < 0.05). CONCLUSIONS: Taken together, these results suggest that nNOS may play an active role in both peripheral and central processing of nociceptive information following orofacial inflammatory pain induction. The regulatory effect of melatonin on nNOS in inflammatory pain may have potential implications for the development of novel analgesic strategies.


Subject(s)
Analgesics/pharmacology , Facial Pain/prevention & control , Hyperalgesia/prevention & control , Melatonin/pharmacology , Nitric Oxide Synthase Type I/metabolism , Nociceptive Pain/prevention & control , Pain Threshold/drug effects , Sensory Receptor Cells/drug effects , Trigeminal Ganglion/drug effects , Trigeminal Nuclei/drug effects , Animals , Cell Line , Disease Models, Animal , Facial Pain/enzymology , Facial Pain/physiopathology , Hyperalgesia/enzymology , Hyperalgesia/physiopathology , Nociceptive Pain/enzymology , Nociceptive Pain/physiopathology , Rats, Sprague-Dawley , Sensory Receptor Cells/enzymology , Trigeminal Ganglion/metabolism , Trigeminal Ganglion/physiopathology , Trigeminal Nuclei/enzymology , Trigeminal Nuclei/physiopathology
6.
J Cell Physiol ; 235(5): 4605-4617, 2020 05.
Article in English | MEDLINE | ID: mdl-31663116

ABSTRACT

Spinal cord injury (SCI) is a devastating disease. Strategies that enhance the intrinsic regenerative ability are very important for the recovery of SCI to radically prevent the occurrence of sensory disorders. Epidermal growth factor (EGF) showed a limited effect on the growth of primary sensory neuron neurites due to the degradation of phosphorylated-epidermal growth factor receptor (p-EGFR) in a manner dependent on Casitas B-lineage lymphoma (CBL) (an E3 ubiquitin-protein ligase). MiR-22-3p predicted from four databases could target CBL to inhibit the expression of CBL, increase p-EGFR levels and neurites length via STAT3/GAP43 pathway rather than Erk1/2 axis. EGF, EGFR, and miR-22-3p were downregulated sharply after injury. In vivo miR-22-3p Agomir application could regulate CBL/p-EGFR/p-STAT3/GAP43/p-GAP43 axis, and restore spinal cord sensory conductive function. This study clarified the mechanism of the limited promotion effect of EGF on adult primary sensory neuron neurite and targeting miR-22-3p could be a novel strategy to treat sensory dysfunction after SCI.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , ErbB Receptors/metabolism , GAP-43 Protein/metabolism , MicroRNAs/metabolism , Nerve Regeneration , Proto-Oncogene Proteins c-cbl/metabolism , STAT3 Transcription Factor/metabolism , Sensory Receptor Cells/enzymology , Spinal Cord Injuries/enzymology , Adaptor Proteins, Signal Transducing/genetics , Animals , Cells, Cultured , Disease Models, Animal , Epidermal Growth Factor/pharmacology , ErbB Receptors/agonists , Evoked Potentials, Somatosensory , Female , MicroRNAs/genetics , Nerve Regeneration/drug effects , Neuronal Outgrowth , Oligonucleotides/pharmacology , Phosphorylation , Primary Cell Culture , Proto-Oncogene Proteins c-cbl/genetics , Rats, Wistar , Recovery of Function , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/pathology , Signal Transduction , Spinal Cord Injuries/drug therapy , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology
7.
Exp Neurol ; 322: 113056, 2019 12.
Article in English | MEDLINE | ID: mdl-31494101

ABSTRACT

Inflammatory response triggered by nerve injury plays important roles in the development of neurological disorders, such as neuropathic pain. The signaling events leading to inflammation in the nervous system remain poorly understood. Here, by deleting Dlk in sensory neurons driven by Wnt1a-Cre, we show that dual leucine zipper kinase (DLK) is required for the neuronal intrinsic immune response to induce cytokines and chemokines such as Ccl2, Ccl7, and Ccl12 upon nerve injury. The DLK-controlled injury response in sensory neurons could regulate CD11b+ immune cell infiltration in the dorsal root ganglia, as well as microgliosis and astrogliosis in the spinal dorsal horn but not the ventral horn. Deficiency of Dlk drastically alleviates the neuropathic pain elicited by chronic constriction injury of the sciatic nerve. Thus, DLK is an essential component that mediates the neuronal intrinsic immune response to nerve injury in sensory neurons and regulates inflammation in the spinal cord.


Subject(s)
Inflammation/enzymology , MAP Kinase Kinase Kinases/immunology , Neuralgia/enzymology , Neuralgia/immunology , Sensory Receptor Cells/enzymology , Animals , Inflammation/immunology , Inflammation/pathology , MAP Kinase Kinase Kinases/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Neuralgia/pathology , Neuroglia/pathology , Sensory Receptor Cells/immunology , Sensory Receptor Cells/pathology
8.
J Neurogenet ; 33(3): 157-163, 2019 09.
Article in English | MEDLINE | ID: mdl-30955404

ABSTRACT

Axonal extension and synaptic targeting are usually completed during early development, but the axonal length and synaptic integrity need to be actively maintained during later developmental stages and the adult life. Failure in the axonal length maintenance and the subsequent axonal degeneration have been associated with neurological disorders, but currently little is known about the genetic factors controlling this process. Here, we show that regulated intracellular levels of cAMP-dependent protein kinase A (PKA) are critical for the axon maintenance during the transition from the early to the later larval stages in the Drosophila class IV dendritic arborization (da) sensory neurons. Our data indicate that when the intracellular levels of PKA are increased via genetic manipulations, these peripheral neurons initially form synapses with wild-type appearance, at their predicted ventral nerve cord (VNC) target sites (in the first and second instar larval stages), but that their synapses disintegrate, and the axons retract and become fragmented in the subsequent larval stages (third larval stage). The affected axonal endings at the disintegrated synaptic sites still express the characteristic presynaptic and cytoskeletal markers such as Bruchpilot and Fascin, indicating that the synapse had been initially properly formed, but that it later lost its integrity. Finally, the phenotype is significantly more prominent in the axons of the neurons whose cell bodies are located in the posterior body segments. We propose that the reason for this is the fact that during the larval development the posterior neurons face a much greater challenge while trying to keep up with the fast-paced growth of the larval body, and that PKA is critical for this process. Our data reveal PKA as a novel factor in the axonal length and synapse integrity maintenance in sensory neurons. These results could be of help in understanding neurological disorders characterized by destabilized synapses.


Subject(s)
Axons/enzymology , Cyclic AMP-Dependent Protein Kinases/metabolism , Neurogenesis/physiology , Sensory Receptor Cells/enzymology , Synapses/enzymology , Animals , Drosophila Proteins/metabolism , Drosophila melanogaster , Larva/enzymology , Larva/growth & development
9.
Elife ; 72018 07 03.
Article in English | MEDLINE | ID: mdl-29968565

ABSTRACT

Neuropathic pain resulting from nerve injury can become persistent and difficult to treat but the molecular signaling responsible for its development remains poorly described. Here, we identify the neuronal stress sensor dual leucine zipper kinase (DLK; Map3k12) as a key molecule controlling the maladaptive pathways that lead to pain following injury. Genetic or pharmacological inhibition of DLK reduces mechanical hypersensitivity in a mouse model of neuropathic pain. Furthermore, DLK inhibition also prevents the spinal cord microgliosis that results from nerve injury and arises distant from the injury site. These striking phenotypes result from the control by DLK of a transcriptional program in somatosensory neurons regulating the expression of numerous genes implicated in pain pathogenesis, including the immune gene Csf1. Thus, activation of DLK is an early event, or even the master regulator, controlling a wide variety of pathways downstream of nerve injury that ultimately lead to chronic pain.


Subject(s)
Gliosis/genetics , Hyperalgesia/genetics , MAP Kinase Kinase Kinases/genetics , Neuralgia/genetics , Peripheral Nerve Injuries/genetics , Sensory Receptor Cells/enzymology , Animals , Disease Models, Animal , Female , Gene Expression Regulation , Gliosis/enzymology , Gliosis/pathology , Gliosis/prevention & control , Hyperalgesia/enzymology , Hyperalgesia/pathology , Hyperalgesia/prevention & control , MAP Kinase Kinase Kinases/deficiency , Macrophage Colony-Stimulating Factor/genetics , Macrophage Colony-Stimulating Factor/metabolism , Male , Mice , Mice, Transgenic , Microglia/enzymology , Microglia/pathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neuralgia/enzymology , Neuralgia/pathology , Neuralgia/prevention & control , Peripheral Nerve Injuries/enzymology , Peripheral Nerve Injuries/pathology , Sciatic Nerve/enzymology , Sciatic Nerve/injuries , Sciatic Nerve/physiopathology , Sensory Receptor Cells/pathology , Signal Transduction , Spinal Cord/enzymology , Spinal Cord/pathology , Touch , Transcription, Genetic
10.
Mol Pain ; 14: 1744806918777406, 2018.
Article in English | MEDLINE | ID: mdl-29712513

ABSTRACT

Irritable bowel syndrome is a disorder of unknown etiology characterized by widespread, chronic abdominal pain associated with altered bowel movements. Increasing amounts of evidence indicate that stressors presented during gestational periods could have long-term effects on the offspring's tissue structure and function, which may predispose to gastrointestinal diseases. The aim of the present study is to determine whether prenatal maternal stressis a adverse factor affecting gastrointestinal sensitivity and to investigate possible mechanisms underlying prenatal maternal stress-induced visceral hypersensitivity in adult offspring. Prenatal maternal stress was induced in pregnant Sprague-Dawley rats by exposure to heterotypic intermitent stress from gestational day 7 to delivery. Prenatal maternal stress significantly increased visceromotor response to colorectal distention in adult offspring from the age of 6 weeks to 10 weeks. Prenatal maternal stress also enhanced neuronal excitability including depolarization of resting membrane potentials, reduction in rheobase, and an increase in the number of action potentials evoked by 2× and 3× rheobase current stimultion of colon-specific dorsal root ganglion neurons. Prenatal maternal stress remarkably enhanced expression of cystathionine-ß-synthase and Nav1.7 in T13-L2 thoracolumbar dorsal root ganglions both at protein and mRNA levels. Intraperitoneal injection of aminooxyacetic acid, an inhibitor of cystathionine-ß-synthase, attenuated prenatal maternal stress-induced visceral hypersensitivity in a dose-dependent manner. A consecutive seven-day administration of aminooxyacetic acid reversed the hyperexcitability of colon-specific dorsal root ganglion neurons and markedly reduced Nav1.7 expression. These results indicate that the presence of multiple psychophysical stressors during pregnancy is associated with visceral hypersensitivity in offspring, which is likely mediated by an upregualtion of cystathionine-ß-synthase and Nav1.7 expression. Prenatal maternal stress might be a significant contributor to irritable bowel syndrome, and cystathionine-ß-synthase might be a potential target for treatment for chronic visceral hypersensitivity in patients with irritable bowel syndrome.


Subject(s)
Cystathionine beta-Synthase/metabolism , Prenatal Exposure Delayed Effects/enzymology , Sensory Receptor Cells/enzymology , Signal Transduction , Stress, Psychological/complications , Visceral Pain/enzymology , Visceral Pain/etiology , Animals , Cells, Cultured , Colon/innervation , Colon/pathology , Cystathionine beta-Synthase/antagonists & inhibitors , Cystathionine beta-Synthase/genetics , Electromyography , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Female , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Ganglia, Spinal/pathology , Male , NAV1.7 Voltage-Gated Sodium Channel/genetics , NAV1.7 Voltage-Gated Sodium Channel/metabolism , Organ Specificity , Pregnancy , Prenatal Exposure Delayed Effects/pathology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/pathology , Signal Transduction/drug effects , Time Factors , Up-Regulation/drug effects , Up-Regulation/genetics , Visceral Pain/pathology
11.
Genes Dev ; 32(5-6): 402-414, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29563183

ABSTRACT

Dendrites possess distinct structural and functional properties that enable neurons to receive information from the environment as well as other neurons. Despite their key role in neuronal function, current understanding of the ability of neurons to regenerate dendrites is lacking. This study characterizes the structural and functional capacity for dendrite regeneration in vivo in adult animals and examines the effect of neuronal maturation on dendrite regeneration. We focused on the class IV dendritic arborization (c4da) neuron of the Drosophila sensory system, which has a dendritic arbor that undergoes dramatic remodeling during the first 3 d of adult life and then maintains a relatively stable morphology thereafter. Using a laser severing paradigm, we monitored regeneration after acute and spatially restricted injury. We found that the capacity for regeneration was present in adult neurons but diminished as the animal aged. Regenerated dendrites recovered receptive function. Furthermore, we found that the regenerated dendrites show preferential alignment with the extracellular matrix (ECM). Finally, inhibition of ECM degradation by inhibition of matrix metalloproteinase 2 (Mmp2) to preserve the extracellular environment characteristics of young adults led to increased dendrite regeneration. These results demonstrate that dendrites retain regenerative potential throughout adulthood and that regenerative capacity decreases with aging.


Subject(s)
Dendrites/physiology , Drosophila/physiology , Matrix Metalloproteinase 2/metabolism , Regeneration , Sensory Receptor Cells/physiology , Aging/physiology , Animals , Dendrites/enzymology , Drosophila/cytology , Drosophila/enzymology , Drosophila Proteins/metabolism , Epidermis/enzymology , Extracellular Matrix/physiology , Gene Expression Regulation, Developmental , Integrins/genetics , Integrins/metabolism , Sensory Receptor Cells/enzymology
12.
Sci Rep ; 8(1): 3263, 2018 02 19.
Article in English | MEDLINE | ID: mdl-29459734

ABSTRACT

The sensory neuron of Aplysia californica participates in several forms of presynaptic plasticity including homosynaptic depression, heterosynaptic depression, facilitation and the reversal of depression. The calcium channel triggering neurotransmitter release at most synapses is CaV2, consisting of the pore forming α1 subunit (CaV2α1), and auxiliary CaVß, and CaVα2δ subunits. To determine the role of the CaV2 channel in presynaptic plasticity in Aplysia, we cloned Aplysia CaV2α1, CaVß, and CaVα2δ and over-expressed the proteins in Aplysia sensory neurons (SN). We show expression of exogenous CaV2α1 in the neurites of cultured Aplysia SN. One proposed mechanism for heterosynaptic depression in Aplysia is through inhibition of CaV2. Here, we demonstrate that heterosynaptic depression of the CaV2 calcium current is inhibited when a channel with a Y-F mutation at the conserved Src phosphorylation site is expressed, showing the strong conservation of this mechanism over evolution. We also show that the Y-F mutation reduces heterosynaptic inhibition of neurotransmitter release, highlighting the physiological importance of this mechanism for the regulation of synaptic efficacy. These results also demonstrate our ability to replace endogenous CaV2 channels with recombinant channels allowing future examination of the structure function relationship of CaV2 in the regulation of transmitter release in this system.


Subject(s)
Aplysia , Calcium Channels/metabolism , Neuronal Plasticity , Receptors, G-Protein-Coupled/antagonists & inhibitors , Sensory Receptor Cells/physiology , Amino Acid Substitution , Animals , Calcium Channels/genetics , Cells, Cultured , Cloning, Molecular , DNA Mutational Analysis , EF Hand Motifs , Protein Subunits/genetics , Protein Subunits/metabolism , Sensory Receptor Cells/enzymology , Tyrosine/genetics
13.
Neuroscience ; 371: 242-253, 2018 02 10.
Article in English | MEDLINE | ID: mdl-29229552

ABSTRACT

The progress of axonal degeneration (AxD) following injury or insult impacts both recovery from axonal transection and protection of axons from diverse insults, or axonopathy. Here we provide evidence that increases in capase-6 (Casp6) expression and action contribute to the progression of AxD. The expression of Casp6 protein and mRNA in distal branches of sensory axons undergoing AxD was confirmed. We developed and utilized a new model of axonopathy in live mice by serially visualizing the viability of cutaneous axons in the ear pinna that expressed an axonal YFP transgene, in response to capasaicin-induced AxD. Both specific pharmacological inhibition of caspase-6 and local knockdown offered early but subtle and mild attenuation of axonopathy. To evaluate an axon autonomous role of Casp6, we examined axon integrity following transection ex vivo, and analyzed the serial morphological fragmentation of neurofilament expression as a structural index of AxD. Adding a specific Casp6 inhibitor to the preparation delayed neurofilament fragmentation. Intact motor axons of Casp6 null mice had normal electrophysiological properties but, as tested serially during AxD, there was attenuated loss of excitability. Following transection, morphological features of AxD were evident in both wild type and Casp6-/- mice but the latter had evidence of slowed progression. Taken together, our findings suggest a subtle but dispensable enabling role of local Casp6 expression in axons undergoing AxD. Serial analysis of cutaneous ear pinna axons in live mice provides a useful and novel model of axonal integrity.


Subject(s)
Axons/enzymology , Caspase 6/metabolism , Nerve Degeneration/enzymology , Sensory Receptor Cells/enzymology , Animals , Axons/pathology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Caspase 6/genetics , Cell Survival/physiology , Ganglia, Spinal/enzymology , Ganglia, Spinal/pathology , Intermediate Filaments/metabolism , Intermediate Filaments/pathology , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Membrane Potentials/physiology , Mice , Nerve Degeneration/pathology , RNA, Messenger/metabolism , Rats , Sciatic Nerve/enzymology , Sciatic Nerve/pathology , Sensory Receptor Cells/pathology
14.
J Cell Biol ; 216(11): 3655-3675, 2017 11 06.
Article in English | MEDLINE | ID: mdl-28877995

ABSTRACT

Axon degeneration is an early event and pathological in neurodegenerative conditions and nerve injuries. To discover agents that suppress neuronal death and axonal degeneration, we performed drug screens on primary rodent neurons and identified the pan-kinase inhibitor foretinib, which potently rescued sympathetic, sensory, and motor wt and SOD1 mutant neurons from trophic factor withdrawal-induced degeneration. By using primary sympathetic neurons grown in mass cultures and Campenot chambers, we show that foretinib protected neurons by suppressing both known degenerative pathways and a new pathway involving unliganded TrkA and transcriptional regulation of the proapoptotic BH3 family members BimEL, Harakiri,and Puma, culminating in preservation of mitochondria in the degenerative setting. Foretinib delayed chemotherapy-induced and Wallerian axonal degeneration in culture by preventing axotomy-induced local energy deficit and preserving mitochondria, and peripheral Wallerian degeneration in vivo. These findings identify a new axon degeneration pathway and a potentially clinically useful therapeutic drug.


Subject(s)
Anilides/pharmacology , Crush Injuries/drug therapy , Mitochondria/drug effects , Neurons/drug effects , Neuroprotective Agents/pharmacology , Protein Kinase Inhibitors/pharmacology , Quinolines/pharmacology , Receptor, trkA/antagonists & inhibitors , Sciatic Nerve/drug effects , Sciatic Neuropathy/drug therapy , Wallerian Degeneration , Adrenergic Fibers/drug effects , Adrenergic Fibers/enzymology , Adrenergic Fibers/pathology , Animals , Apoptosis/drug effects , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Axons/drug effects , Axons/enzymology , Axons/pathology , Cells, Cultured , Crush Injuries/enzymology , Crush Injuries/genetics , Crush Injuries/pathology , Cytoprotection , Disease Models, Animal , Dose-Response Relationship, Drug , Genotype , Mice, Inbred C57BL , Mice, Transgenic , Mitochondria/enzymology , Mitochondria/pathology , Motor Neurons/drug effects , Motor Neurons/enzymology , Motor Neurons/pathology , Mutation , Neurons/enzymology , Neurons/pathology , Phenotype , Phosphorylation , Rats, Sprague-Dawley , Receptor, trkA/genetics , Receptor, trkA/metabolism , Sciatic Nerve/enzymology , Sciatic Nerve/injuries , Sciatic Nerve/pathology , Sciatic Neuropathy/enzymology , Sciatic Neuropathy/genetics , Sciatic Neuropathy/pathology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/enzymology , Sensory Receptor Cells/pathology , Signal Transduction , Superoxide Dismutase-1/genetics , Superoxide Dismutase-1/metabolism , Time Factors , Transcription, Genetic
15.
Nat Commun ; 8: 15124, 2017 05 11.
Article in English | MEDLINE | ID: mdl-28492233

ABSTRACT

Mammalian A-type proteins, ISCA1 and ISCA2, are evolutionarily conserved proteins involved in iron-sulfur cluster (Fe-S) biogenesis. Recently, it was shown that ISCA1 and ISCA2 form a heterocomplex that is implicated in the maturation of mitochondrial Fe4S4 proteins. Here we report that mouse ISCA1 and ISCA2 are Fe2S2-containing proteins that combine all features of Fe-S carrier proteins. We use biochemical, spectroscopic and in vivo approaches to demonstrate that despite forming a complex, ISCA1 and ISCA2 establish discrete interactions with components of the late Fe-S machinery. Surprisingly, knockdown experiments in mouse skeletal muscle and in primary cultures of neurons suggest that ISCA1, but not ISCA2, is required for mitochondrial Fe4S4 proteins biogenesis. Collectively, our data suggest that cellular processes with different requirements for ISCA1, ISCA2 and ISCA1-ISCA2 complex seem to exist.


Subject(s)
Aconitate Hydratase/metabolism , Iron-Sulfur Proteins/metabolism , Mitochondrial Proteins/metabolism , Muscle, Skeletal/enzymology , Sensory Receptor Cells/enzymology , Aconitate Hydratase/genetics , Animals , Binding Sites , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Female , Gene Expression , Genetic Vectors/chemistry , Genetic Vectors/metabolism , Iron-Sulfur Proteins/genetics , Male , Mice , Mice, Inbred C57BL , Mitochondrial Proteins/genetics , Primary Cell Culture , Protein Binding , Protein Interaction Domains and Motifs , Protein Multimerization , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sensory Receptor Cells/cytology , Spectroscopy, Mossbauer
16.
Neuroscience ; 352: 97-105, 2017 06 03.
Article in English | MEDLINE | ID: mdl-28389375

ABSTRACT

Striatal-enriched phosphatase 61 (STEP61) is a member of intracellular protein tyrosine phosphatases, which is involved in the regulation of synaptic plasticity and a line of neuropsychiatric disorders. This protein tyrosine phosphatase is also abundant in pain-related spinal cord dorsal horn neurons. However, whether and how this tyrosine phosphatase modulates the nociceptive plasticity and behavioral hypersensitivity remain largely unknown. The present study recorded the long-term potentiation (LTP) of primary afferent C fiber-evoked field potentials in vivo in superficial dorsal horn of rats, and tested the possible role of STEP61 in spinal LTP. We found that LTP induction significantly increased STEP61 phosphorylation at Ser221 residue, a key molecular event that has been shown to impair the phosphatase activity. The STEP61 hypoactivity allowed for the activation of three substrates, GluN2B subunit-containing N-methyl-d-aspartate-subtype glutamate receptors, Src-family protein tyrosine kinase member Fyn and extracellular signal-regulated kinase 1/2, through which the thresholds for LTP induction were noticeably decreased. To reinstate STEP61 activity, we overexpressed wild-type STEP61 [STEP61(WT)] in spinal dorsal horn, finding that STEP61(WT) completely blunted LTP induction. Behavioral tests showed that LTP blockade by STEP61(WT) correlated with a long-lasting alleviation of thermal hypersensitivity and mechanical allodynia induced by chronic constriction injury of sciatic nerves. These data implicated that STEP61 exerted a negative control over spinal nociceptive plasticity, which might have therapeutic benefit in pathological pain.


Subject(s)
Long-Term Potentiation/physiology , Neuralgia/pathology , Protein Tyrosine Phosphatases/metabolism , Sensory Receptor Cells/enzymology , Spinal Cord Dorsal Horn/pathology , Afferent Pathways/physiopathology , Animals , Butadienes/pharmacology , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hyperalgesia/pathology , Long-Term Potentiation/drug effects , Male , Nerve Fibers/physiology , Nitriles/pharmacology , Pain Measurement , Protein Tyrosine Phosphatases/genetics , Proto-Oncogene Proteins c-fyn/metabolism , Rats , Rats, Sprague-Dawley , Sensory Receptor Cells/drug effects , Transduction, Genetic
17.
eNeuro ; 4(1)2017.
Article in English | MEDLINE | ID: mdl-28197555

ABSTRACT

The MAPK isoforms ERK and p38 MAPK are believed to play opposing roles in long-term synaptic facilitation (LTF) induced by serotonin (5-HT) in Aplysia. To fully understand their roles, however, it is necessary to consider the dynamics of ERK and p38 MAPK activation. Previous studies determined that activation of ERK occurred ∼45 min after a 5-min pulse of 5-HT treatment. The dynamics of p38 MAPK activation following 5-HT are yet to be elucidated. Here, the activity of p38 MAPK was examined at different times after 5-HT, and the interaction between the ERK and p38 MAPK pathways was investigated. A 5-min pulse of 5-HT induced a transient inhibition of p38 MAPK, followed by a delayed activation between 25 and 45 min. This activation was blocked by a MAPK kinase inhibitor, suggesting that similar pathways are involved in activation of ERK and p38 MAPK. ERK activity decreased shortly after the activation of p38 MAPK. A p38 MAPK inhibitor blocked this decrease in ERK activity, suggesting a causal relationship. The p38 MAPK activity ∼45 min after different stimulus protocols was also characterized. These data were incorporated into a computational model for the induction of LTF. Simulations and empirical data suggest that p38 MAPK, together with ERK, contributes to the efficacy of spaced stimulus protocols to induce LTF, a correlate of long-term memory (LTM). For example, decreased p38 MAPK activity ∼45 min after the first of two sensitizing stimuli might be an important determinant of an optimal interstimulus interval (ISI) for LTF induction.


Subject(s)
Long-Term Potentiation/physiology , Serotonin/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Aplysia , Cells, Cultured , Computer Simulation , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Fluorescent Antibody Technique , Long-Term Potentiation/drug effects , Mitogen-Activated Protein Kinase Kinases/metabolism , Models, Neurological , Phosphorylation/physiology , Protein Kinase Inhibitors/pharmacology , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/enzymology , Time Factors , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors
18.
PLoS One ; 12(1): e0169882, 2017.
Article in English | MEDLINE | ID: mdl-28118359

ABSTRACT

Voltage-gated sodium channels (VGSC) regulate neuronal excitability by governing action potential (AP) generation and propagation. Recent studies have revealed that AMP-activated protein kinase (AMPK) activators decrease sensory neuron excitability, potentially by preventing sodium (Na+) channel phosphorylation by kinases such as ERK or via modulation of translation regulation pathways. The direct positive allosteric modulator A769662 displays substantially greater efficacy than other AMPK activators in decreasing sensory neuron excitability suggesting additional mechanisms of action. Here, we show that A769662 acutely inhibits AP firing stimulated by ramp current injection in rat trigeminal ganglion (TG) neurons. PT1, a structurally dissimilar AMPK activator that reduces nerve growth factor (NGF) -induced hyperexcitability, has no influence on AP firing in TG neurons upon acute application. In voltage-clamp recordings, application of A769662 reduces VGSC current amplitudes. These findings, based on acute A769662 application, suggest a direct channel blocking effect. Indeed, A769662 dose-dependently blocks VGSC in rat TG neurons and in Nav1.7-transfected cells with an IC50 of ~ 10 µM. A769662 neither displayed use-dependent inhibition nor interacted with the local anesthetic (LA) binding site. Popliteal fossa administration of A769662 decreased noxious thermal responses with a peak effect at 5 mins demonstrating an analgesic effect. These data indicate that in addition to AMPK activation, A769662 acts as a direct blocker/modulator of VGSCs, a potential mechanism enhancing the analgesic property of this compound.


Subject(s)
AMP-Activated Protein Kinases/drug effects , Analgesics/pharmacology , NAV1.7 Voltage-Gated Sodium Channel/drug effects , Pyrones/pharmacology , Sensory Receptor Cells/drug effects , Sodium Channel Blockers/pharmacology , Thiophenes/pharmacology , Anesthetics, Local/metabolism , Animals , Binding Sites/genetics , Biphenyl Compounds , Drug Evaluation, Preclinical , HEK293 Cells , Hot Temperature/adverse effects , Humans , Male , Metformin/pharmacology , NAV1.7 Voltage-Gated Sodium Channel/genetics , Neural Conduction/drug effects , Pain/drug therapy , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Recombinant Fusion Proteins/drug effects , Recombinant Fusion Proteins/metabolism , Resveratrol , Sensory Receptor Cells/enzymology , Stilbenes/pharmacology , Thiazoles/pharmacology , Trigeminal Ganglion/drug effects , meta-Aminobenzoates/pharmacology
19.
Cephalalgia ; 37(14): 1373-1383, 2017 Dec.
Article in English | MEDLINE | ID: mdl-27884929

ABSTRACT

Background Blocking the pro-nociceptive action of CGRP is one of the most promising approaches for migraine prophylaxis. The aim of this study was to explore a role for CGRP as a neuroprotective agent for central and peripheral neurons. Methods The viability of isolated rat trigeminal, cortical and cerebellar neurons was tested by fluorescence vital assay. Engagement of Nrf2 target genes was analyzed by qPCR. The neuroprotective efficacy of CGRP in vivo was tested in mice using a permanent cerebral ischemia model. Results CGRP prevented apoptosis induced by the amino acid homocysteine in all three distinct neuronal populations. Using a set of specific kinase inhibitors, we show the role of multi-kinase signaling pathways involving PKA and CaMKII in neuronal survival. Forskolin triggered a very similar signaling cascade, suggesting that cAMP is the main upstream trigger for multi-kinase neuroprotection. The specific CGRP antagonist BIBN4096 reduced cellular viability, lending further support to the proposed neuroprotective function of CGRP. Importantly, CGRP was neuroprotective against permanent ischemia in mice. Conclusion Our data show an unexpected 'positive' role for the endogenous pro-nociceptive migraine mediator CGRP, suggesting more careful examination of migraine prophylaxis strategy based on CGRP antagonism although it should be noted that homocysteine induced apoptosis in primary neuronal cell culture might not necessarily reproduce all the features of cell loss in the living organism.


Subject(s)
Calcitonin Gene-Related Peptide/therapeutic use , Cerebellum/enzymology , Cerebral Cortex/enzymology , Migraine Disorders/enzymology , Nociception/drug effects , Sensory Receptor Cells/enzymology , Animals , Calcitonin Gene-Related Peptide/pharmacology , Cells, Cultured , Cerebellum/diagnostic imaging , Cerebellum/drug effects , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/drug effects , Male , Migraine Disorders/diagnostic imaging , Migraine Disorders/drug therapy , Neurons/drug effects , Neurons/enzymology , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Nociception/physiology , Rats , Rats, Wistar , Sensory Receptor Cells/drug effects , Signal Transduction/drug effects , Signal Transduction/physiology , Trigeminal Ganglion/diagnostic imaging , Trigeminal Ganglion/drug effects , Trigeminal Ganglion/enzymology
20.
J Pharmacol Exp Ther ; 359(2): 319-328, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27605628

ABSTRACT

A single administration of the κ opioid receptor (KOR) antagonist, norbinaltorphimine (norBNI), produces long-term reduction in KOR function in heterologous expression systems and brain that is mediated by activation of c-Jun N-terminal kinase (JNK). In this study, we examined the long-term effects of norBNI on adult rat peripheral sensory neurons in vivo and ex vivo. Following a single intraplantar (i.pl.) injection of norBNI into the hind paw, peripheral KOR-mediated antinociception in the ipsilateral, but not the contralateral, hindpaw was abolished for at least 9 days. By contrast, the antinociceptive response to mu and delta opioid receptor agonists was unaltered. The long-term inhibitory effect on antinociception produced by pretreatment with norBNI required occupancy of peripheral KOR and was completely blocked by i.pl. injection of the JNK inhibitor, SP600125. In cultures of peripheral sensory neurons, norBNI activated JNK for at least 30 minutes. Furthermore, norBNI blocked KOR-mediated inhibition of adenylyl cyclase activity measured 24 hours later in a JNK-dependent manner, but did not block activation of extracellular signal-regulated kinase (ERK). The long-term inhibitory effect of norBNI on KOR function in vivo and ex vivo was blocked by inhibitors of mRNA translation, cycloheximide and rapamycin. These data suggest that in peripheral sensory neurons norBNI is a KOR-biased ligand for activation of JNK signaling, resulting in long-term blockade of some (antinociception, inhibition of adenylyl cyclase activity), but not all (ERK), KOR signaling. Importantly, norBNI elicits de novo protein synthesis in sensory neuron terminals that produces selective long-term regulation of KOR.


Subject(s)
JNK Mitogen-Activated Protein Kinases/metabolism , Naltrexone/analogs & derivatives , Protein Biosynthesis/drug effects , Receptors, Opioid, kappa/antagonists & inhibitors , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/metabolism , Animals , Dinoprostone/pharmacology , Enzyme Activation/drug effects , Hyperalgesia/drug therapy , Ligands , Male , Naltrexone/metabolism , Naltrexone/pharmacology , Naltrexone/therapeutic use , Rats , Rats, Sprague-Dawley , Receptors, Opioid, kappa/metabolism , Sensory Receptor Cells/cytology , Sensory Receptor Cells/enzymology , Signal Transduction/drug effects , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL